Moderna
Moderna is an American biotechnology company that develops messenger RNA-based vaccines and therapies. It is best known for developing the first widely used COVID-19 vaccine based on mRNA technology and for building a broad pipeline across infectious disease and oncology. It remains relevant in current news due to ongoing vaccine updates, regulatory developments, and the broader adoption of mRNA technology in public health and medicine.
Connections
OpenAI Broadens Access to GPT-Rosalind for Life Sciences Research
OpenAI has widened access to its GPT-Rosalind model, currently available to enterprise giants such as Amgen and Moderna. This development aims to accelerate biological and drug discovery research through broader deployment of advanced AI tools.
Moderna Settles Patent Dispute with Roivant for Up to $2.25 Billion
Moderna has settled a patent lawsuit with Roivant for up to $2.25 billion, ending a major legal dispute. This settlement comes amidst broader efforts to lower drug costs and could influence future vaccine development and pricing.